BlackRock Fund Advisors’s vTv Therapeutics VTVT Stock Holding History

BlackRock Fund Advisors’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.18M	Buy	6,130 +798	+15%	+$183K	﹤0.01%	3216
2016 Q3	$1.53M	Buy	5,332 +277	+5%	+$66.7K	﹤0.01%	3193
2016 Q2	$1.17M	Buy	5,055 +1,063	+27%	+$245K	﹤0.01%	3252
2016 Q1	$824K	Sell	3,992 -221	-5%	-$55K	﹤0.01%	3202
2015 Q4	$1.15M	Buy	4,213 +547	+15%	+$154K	﹤0.01%	3219
2015 Q3	$956K	Buy	+3,666	New	+$1.28M	﹤0.01%	3208

Other funds holding VTVT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's VTVT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its vTv Therapeutics (VTVT) stake by 15% in Q4 2016, buying an estimated $183K and bringing the position to 6,130 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #3216.

BlackRock Fund Advisors first reported a position in VTVT in Q3 2015 and has held it in 6 quarters since. The position peaked at $1.53M in Q3 2016. 44 funds tracked by Wall St. Rank hold VTVT as of Q4 2016.

BlackRock Fund Advisors held 6,130 shares of vTv Therapeutics worth $1.18M as of Q4 2016.
BlackRock Fund Advisors bought 798 vTv Therapeutics shares in Q4 2016, an estimated $183K.
vTv Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3216 holding.
BlackRock Fund Advisors first reported a position in vTv Therapeutics in Q3 2015 and has held it in 6 quarters since.
BlackRock Fund Advisors's vTv Therapeutics position peaked at $1.53M in Q3 2016.
44 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.